On Dec. 3, 1984, the worst industrial accident in history unfolded in India. No punishment meted out has fit the immensity of the wrongdoing
With aviation fanatics keeping a close watch outside aircraft factories, little is secret
With Walmart workers promising their biggest strike, here's how to understand the action on Black Friday
How Anita Sarkeesian is trying to change the $25 billion video game industry
Subsidies from developers can lower interest rates to zero
Holiday gifts for every workstation in life, whether you're fetching coffee, announcing your IPO, or playing tennis all day
Graduate students get paid close to the minimum wage to do high-level coding work for tech companies
A look at how business owners profiled in Bloomberg Businessweek are coping with the latest unrest
King of Prussia, Pa.
Founders: Dr. Robert Lefkowitz and Dr. Howard Rockman
VC Investment over the last four quarters: $26.1 million
Trevena, founded in January 2008, is a drug discovery company developing pharmaceuticals that target what are known as G-protein coupled receptors. Such drugs make up more than 40% of marketed drugs today, according to Trevena. The company's drug discovery platform is based on research from Duke University Medical Center, including that of founder and National Medal of Science winner Robert Lefkowitz.
Key to startup success: "We've been able to generate the strong investor support for this idea [because] the technology and the opportunity here is very, very unique, and the possibility of unlocking new areas of biology is so significantly different from what's currently out there."